As previously reported in issue 24, Glatt Weimar
has been appointed as general contractor of a blood
plasma fractionizing plant in Kirov, Russia. The
project has been financed by the Russian Health Ministry,
which due to its impressive size has not only captured
the interest of the public, but also the attention
of politicians.
read
more . . .